scispace - formally typeset
D

Daniel Prieto-Alhambra

Researcher at University of Oxford

Publications -  438
Citations -  11189

Daniel Prieto-Alhambra is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 45, co-authored 345 publications receiving 7269 citations. Previous affiliations of Daniel Prieto-Alhambra include Erasmus University Medical Center & Mount Vernon Hospital.

Papers
More filters
Journal ArticleDOI

Global epidemiology of hip fractures: a study protocol using a common analytical platform among multiple countries

TL;DR: In this paper, the authors investigated global trends in hip fracture incidence, mortality and use of postfracture pharmacological treatment across Asia, Oceania, North and South America, and Western and Northern Europe using a unified methodology applied to health records.
Journal ArticleDOI

CPRD GOLD and linked ONS mortality records: Reconciling guidelines.

TL;DR: Recommendations on how to manage mortality data coming from both GOLD and linked ONS, taking into account linkage coverage period, linkage correctness likelihood, linkage regional limitations and data discrepancies between these two datasets are developed.
Journal ArticleDOI

Factors Associated With Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries

TL;DR: The results suggest that the main factors driving treatment choice at any stage of intensification were age, hemoglobin A1c, BMI, renal and cardiac morbidity, and treatment history, which were consistent with guidelines on, and contraindications of, specific medications.
Journal ArticleDOI

Smoking and COVID-19 Infection and Related Mortality: A Prospective Cohort Analysis of UK Biobank Data

TL;DR: In this article, a prospective study with participants from the UK Biobank cohort was conducted to examine association between smoking and COVID-19 infection and subsequent mortality, and the authors found that older smokers were twice more likely to die from COVID19 than never smokers, possibly mediated by increased risk of chronic conditions or illnesses.